
ABSTRACT Background: Primary bone tumours are rare neoplasms with significant clinical implications owing to their potential for local destruction and metastasis. An accurate diagnosis relies on an integrated approach that combines radiological imaging and histopathological examination. Aims: This study aimed to analyse the histopathological spectrum of primary bone tumours, evaluate radiological–histopathological concordance and highlight the diagnostic challenges in Northeast India. Materials and Methods: A retrospective study was conducted over 5 years (2020–2024). A total of 113 primary bone tumour specimens, mostly Tru-Cut biopsy specimens and a few excision biopsy specimens, were evaluated. Tumours were classified according to the World Health Organization 2020 classification, and radiological findings (X-ray, computed tomography [CT] and magnetic resonance imaging [MRI]) were compared with histopathological diagnoses to determine concordance rates. Immunohistochemistry and molecular testing were not performed in this study. The data were analysed using statistical methods, including Cohen’s kappa coefficient for agreement. Results: Giant cell tumours (31.0%) were the most common primary bone tumours, followed by osteosarcoma (21.2%), osteochondroma (15.0%), small round cell tumours/round cell sarcomas (not further classified; 6.2%), chondrosarcoma (5.3%), aneurysmal bone cyst (4.4%), enchondroma (4.4%) and others (12.4%). The tumours predominantly affected the femur (40.7%) and tibia (25.7%). The mean age was 27.6 years, with a slight male predominance (male: female = 1.02:1). The overall radiological–histopathological concordance was 88.5% (100/113), with an overall Cohen’s kappa value of 0.86. Modality-wise concordance was 86.9% for radiography, 90.0% for CT and 91.7% for MRI. Conclusion: An integrated diagnostic approach incorporating advanced imaging and histopathological analysis is crucial for accurate diagnosis and management. Regional epidemiological variations emphasise the need for localised studies to address specific diagnostic challenges and optimise patient outcomes.
ABSTRACT Cardiometabolic and respiratory disorders are increasingly recognised as major contributors to severe maternal morbidity; however, they continue to be examined largely in isolation in both research and clinical practice. Across recent literature, there is a growing suggestion – not always explicitly stated – that conditions such as obesity, sleep-disordered breathing, pulmonary hypertension and heart failure with preserved ejection fraction may not operate independently, but rather intersect through overlapping physiological stress pathways unique to pregnancy. Therefore, this review aimed to explore whether these coexisting conditions might be better understood within an integrated framework rather than as discrete entities. In line with PRISMA guidance, we systematically searched major databases and registries, using predefined criteria to guide study selection and synthesis. After removing duplicates and screening the available reports, we included 33 studies. Despite differences in study design and diagnostic definitions, particularly for heart failure phenotypes, a consistent pattern has emerged: metabolic inflammation, endothelial dysfunction, intermittent hypoxia, impaired ventricular relaxation and progressive pulmonary vascular load have recurred across the literature. These processes, often described separately, seem to cluster and intensify across gestation, potentially narrowing the cardiopulmonary reserve and amplifying the haemodynamic strain. Clinically, this convergence is associated with increased rates of hypertensive complications, pre-term birth, foetal growth restriction, respiratory compromise and peri-partum instability. However, the heterogeneity of the available evidence and the absence of standardised definitions limit direct comparability and preclude causal inference. Taken together, these findings support the proposed integrative interpretation of the interaction between cardiometabolic and respiratory dysfunction during pregnancy. Further prospective and mechanistic studies are needed to clarify these relationships and determine whether earlier recognition of such patterns can improve maternal and foetal outcomes.
ABSTRACT Background: Antimicrobial resistance is a major global health threat, and a substantial proportion of antibiotic exposure in hospitals appears to be directed at microbial colonisation rather than true infection. Therefore, distinguishing pathogens from colonisers at the point of care is central to antimicrobial and diagnostic stewardship. Objective: To synthesise current evidence on differentiating pathogenic infections from asymptomatic colonisation in common clinical scenarios and to provide practical, bedside-oriented frameworks that support safer, more targeted antimicrobial use. Methods: We conducted a structured narrative review of randomised and quasi-randomised trials, systematic reviews, large observational studies and major guideline documents published between January 1990 and December 2024, focussing on six syndromes where misclassification of colonisation as infection is frequent: asymptomatic bacteriuria (ASB), ventilator-associated tracheobronchitis versus ventilator-associated pneumonia, coagulase-negative staphylococci and other skin commensals in blood cultures, chronic wound colonisation, candiduria and mucosal Candida colonisation and colonisation of surgical drains. Evidence on quantitative culture thresholds, biomarkers (particularly procalcitonin) and diagnostic stewardship interventions was qualitatively synthesised. Results: Across the six syndromes, consistent data suggest that withholding systemic antibiotics for clearly defined colonisation is generally safe in immunocompetent, clinically stable patients and is associated with substantial reductions in antibiotic use and adverse drug events without convincing evidence of increased mortality or progression to invasive infection in most studied settings. At the same time, the literature highlights specific high-risk groups, such as neutropenic hosts, patients with recent surgery or instrumentation and haemodynamically unstable intensive care unit patients, in whom a lower threshold for treatment or closer monitoring remains appropriate. Evidence regarding ventilator-associated tracheobronchitis, advanced diagnostic modalities for ventilator-associated pneumonia and biomarker-guided strategies such as procalcitonin remains heterogeneous and should be interpreted in the context of ongoing clinical controversies. Conclusions: Accurate discrimination between colonisation and infection should be regarded as a core clinical competency by prescribers. Applying syndrome-specific criteria, integrating biomarkers judiciously and embedding diagnostic stewardship into institutional practice can reduce unnecessary antimicrobial exposure while maintaining patient safety. Summary tables and practical algorithms may facilitate bedside implementation and education.
ABSTRACT Neonatal sepsis due to Salmonella typhi is rare but can lead to life-threatening complications. The clinical manifestations are generally similar to those of sepsis caused by other Gram-negative pathogens in newborns. The exact route of transmission remains unclear, with both vertical and horizontal spread proposed. Diagnosis is confirmed by isolating the organism through blood cultures. Management primarily involves supportive care and intravenous antibiotic therapy. We present the case of a 21-day-old neonate admitted to our neonatal intensive care unit with clinical features of sepsis, which was subsequently confirmed to be S. typhi sepsis with meningitis.